Abstract

BackgroundDepression and depressive symptoms are highly prevalent in old persons but are potentially reversible. Full recovery is the main goal in the treatment of depressive episodes. Compared to clinical trials, observational studies of patients with depression in late life (DLL) show poorer prognoses in terms of response and remission. However, observational studies on the course of DLL are scarce.The aims of this study were to examine the course of DLL in terms of response, remission and symptom-specific changes as measured by the Montgomery and Asberg Depression Rating Scale (MADRS), and to explore which clinical variables were associated with the response and remission.MethodsThis is an observational, multicenter and prospective study of patients aged 60 years and older who were referred to treatment of depression in the department of old-age psychiatry at specialist health care services in Norway. The patients were evaluated with the MADRS at admission to and discharge from hospital. The mean, median, minimum and maximum values for days stayed in hospital were 68, 53, 16 and 301, respectively.Effect size (ES) was calculated to determine which MADRS symptoms changed most during the treatment. To assess the predictors for change in the MADRS score (continuous variable) and for remission and response (both dichotomous variables), regression models adjusting for cluster effects within center were estimated.ResultsOf 145 inpatients, 99 (68.3 %) had a response to treatment (50 % or more improvement of the MADRS score). Remission (MADRS score ≤9 at discharge) was experienced in 74 (51.0 %) of the patients. Of the individual MADRS items, “reported sadness” (ES =0.88) and “lassitude” (ES = 0.80) showed the greatest amount of improvement, and “concentration difficulties” (ES = 0.50) showed the least amount of improvement during treatment. Having a diagnosis of dementia was associated with a lower remission rate and less improvement in the MADRS score during the treatment. Poorer physical health was associated with a lower response rate. Having experienced previous episode(s) of depression was associated with a lower remission rate.ConclusionsRecurrent episodes of depression, poor somatic health and a diagnosis of dementia were found to be negative prognostic factors for the course of DLL. Clinicians should therefore pay close attention to these factors when evaluating treatment.Trial registrationClinicalTrials.gov NCT01952366.

Highlights

  • Depression and depressive symptoms are highly prevalent in old persons but are potentially reversible

  • Psychotropic drugs were used by 91.7 % and 95.2 % of patients at inclusion and at discharge, respectively (p = 0.27)

  • There were no differences in Defined Daily Dose (DDD) among those using the drug at both time points

Read more

Summary

Introduction

Depression and depressive symptoms are highly prevalent in old persons but are potentially reversible. Observational studies of patients with depression in late life (DLL) show poorer prognoses in terms of response and remission. Depressive episodes in old persons are potentially reversible, and full recovery is the main goal of treatment [7]. Prospective observational studies of inpatients have shown lower recovery rates from depressive episodes in old persons, varying from 38–69 % [8, 9]. A clinical profile of an old depressed patient with conditions such as comorbid anxiety, psychotic symptoms, poor self-esteem, poor sleep, medical comorbidity and coexisting cognitive impairment is associated with a poorer prognosis in terms of response and remission [7, 11]. Guidelines for diagnosing and managing DLL [12] as well as strategies for improving recovery rates have been developed [7]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.